ACTRN12614001287628尚未招募2 期
patients with locally resectable pancreatic cancerrandomized to standard preoperative assessment or additional primovist MRI to further evaluate for liver metastasescomparing 12 month recurrence rate between the 2 groups
jai seema bagia0 个研究点目标入组 24 人开始时间: 2014年12月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Sex: Male and Females
- •Age range: 18-85
- •Disease status: Locally operable pancreatic adenocarcinoma diagnosed by CT +- elevated tumour markers +- cholangiography +- cytology.
- •No liver metastases on CT staging.
排除标准
- •Patients with significant renal impairment, which precludes them having the CT, contrast or Primovist contrast for the MRI would be excluded.
- •Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
- •Patients with a history of renal disease with an EGFR less than 40.
- •Patients with a history of a psychological illness or condition such as to interfere with the patient's ability to understand the requirements of the study.
- •Patients with devices that exclude them from Primovist MRI will be excluded from the study, in particular, patients with pacemakers and/or implantable devices.
- •Patients unwilling and unable to give written informed consent to participate in the study. Patients unable to understand study information with the help of an interpreter.
研究者
相似试验
已完成
不适用
Observational study of pancreatic cancer patients with positive peritoneal lavage cytologypancreatic cancerJPRN-UMIN000032477Shizuoka Cancer Center150
招募中
不适用
Pancreatic Locally advanced Irresectable Cancer AblatioN (PELICAN trial)Locally advanced pancreatic cancernon-resectabel pancreatic tumor10017998NL-OMON56404Amsterdam UMC174
终止
1 期
Investigation of gemcitabine combined with temsirolimus, in patients with inoperable or metastatic pancreatic cancer. A phase I-II study by the Hellenic Cooperative Oncology Group with biomarker evaluation (HE3/07)Patients with inoperable or metastatic pancreatic cancerCancer - PancreaticACTRN12611000643976Hellenic Cooperative Oncology Group85
进行中（未招募）
1 期
A study in patients with borderline unresectable pancreatic cancer, where Abraxane and Gemcitabine will be administered with the goal of shrinking tumours to make them operable.ocally advanced pancreatic cancerMedDRA version: 17.0 Level: LLT Classification code 10033606 Term: Pancreatic cancer non-resectable System Organ Class: 100000004864EUCTR2013-004200-19-GBCambridge University Hospitals NHS Foundation Trust and the University of Cambridge9
招募中
2 期
PANcreatic Cancer lOcalized disease in frail or elderly patients unfit for both chemotherapy and surgery treated with Stereotactic Ablative Radiotherapy (PANCOSAR): a multicenter randomized controlled trialpancreatic cancerNL-OMON52822Vrije Universiteit Medisch Centrum98